For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Jonathan Chilton-Towle
Jonathan Chilton-Towle

Jonathan is a senior journalist at Pharmacy Today, and has been with us since 2016. He is based in Wellington.
Articles by Jonathan Chilton-Towle
Pagination
Article archive
How to Treat
Wednesday 28 May 2025, 12:50 AM
Latest news
10/06/2025
06/06/2025